0 Évaluations
ID

37684

Description

Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT01788189

Lien

https://clinicaltrials.gov/show/NCT01788189

Mots-clés

Versions (2)
  1. 16/08/2019 16/08/2019 -
  2. 16/08/2019 16/08/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

16 août 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility B-cell Lymphoma NCT01788189

    Anglais

    Eligibility B-cell Lymphoma NCT01788189

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    age ≥ 18 years
    Description

    Age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    performance status ecog 0 - 3
    Description

    ECOG performance status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    first or subsequent relapse or refractoriness of a biopsy-proven cd20-positive aggressive b cell lymphoma (excluding mantle cell lymphoma)
    Description

    Recurrent Aggressive Adult Non-Hodgkin Lymphoma B-Cell CD20 positive | Non-Hodgkin's lymphoma aggressive refractory B-Cell CD20 positive | Exception Mantle cell lymphoma

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0677726
    UMLS CUI [1,2]
    C0004561
    UMLS CUI [1,3]
    C3888518
    UMLS CUI [2,1]
    C0854870
    UMLS CUI [2,2]
    C0004561
    UMLS CUI [2,3]
    C3888518
    UMLS CUI [3,1]
    C1705847
    UMLS CUI [3,2]
    C0334634
    measurable disease
    Description

    Measurable Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    ineligibility or unwillingness to undergo high-dose chemotherapy with autologous stem cell transplantation
    Description

    Ineligibility High-Dose Chemotherapy with Autologous Stem Cell Transplant | High-Dose Chemotherapy with Autologous Stem Cell Transplant Unwilling

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C1512714
    UMLS CUI [1,2]
    C1512429
    UMLS CUI [2,1]
    C1512429
    UMLS CUI [2,2]
    C0558080
    ability to understand the aim of the study and act accordingly
    Description

    Comprehension Study Protocol | Protocol Compliance

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0162340
    UMLS CUI [1,2]
    C2348563
    UMLS CUI [2]
    C0525058
    effective contraception
    Description

    Contraceptive methods

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0700589
    signed informed consent
    Description

    Informed Consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    central nervous system relapse of aggressive lymphoma
    Description

    Central nervous system lymphoma Aggressive Relapse

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0280803
    UMLS CUI [1,2]
    C0580822
    UMLS CUI [1,3]
    C0205336
    any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study
    Description

    Medical condition Study Subject Participation Status Excluded | Laboratory test result abnormal Study Subject Participation Status Excluded | Mental disorder Study Subject Participation Status Excluded

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C3843040
    UMLS CUI [1,2]
    C2348568
    UMLS CUI [1,3]
    C0332196
    UMLS CUI [2,1]
    C0438215
    UMLS CUI [2,2]
    C2348568
    UMLS CUI [2,3]
    C0332196
    UMLS CUI [3,1]
    C0004936
    UMLS CUI [3,2]
    C2348568
    UMLS CUI [3,3]
    C0332196
    any condition including the presence of laboratory abnormalities which places the subject at unacceptable risk if he/she were to participate in the study
    Description

    Condition Study Subject Participation Status At risk | Laboratory test result abnormal Study Subject Participation Status At risk

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0348080
    UMLS CUI [1,2]
    C2348568
    UMLS CUI [1,3]
    C1444641
    UMLS CUI [2,1]
    C0438215
    UMLS CUI [2,2]
    C2348568
    UMLS CUI [2,3]
    C1444641
    any condition that confounds the ability to interpret data from the study
    Description

    Condition Interferes with Interpretation Research data

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0348080
    UMLS CUI [1,2]
    C0521102
    UMLS CUI [1,3]
    C0459471
    UMLS CUI [1,4]
    C0681873
    inadequate organ function not related to aggressive lymphoma:
    Description

    Organ function Inadequate | Relationship Absent Aggressive Lymphoma

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0678852
    UMLS CUI [1,2]
    C0205412
    UMLS CUI [2,1]
    C0439849
    UMLS CUI [2,2]
    C0332197
    UMLS CUI [2,3]
    C1332225
    neutrophils < 1.0/nl
    Description

    Neutrophil count

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0200633
    platelets < 75/nl
    Description

    Platelet Count measurement

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032181
    creatinine clearance < 60 ml/min
    Description

    Creatinine clearance measurement

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0373595
    bilirubin ≥ 2,5 mg/dl
    Description

    Bilirubin measurement

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0344395
    serum ast/got or alt/gpt ≥ 4 x upper limit of normal
    Description

    Aspartate aminotransferase increased | Alanine aminotransferase increased

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0151904
    UMLS CUI [2]
    C0151905
    active viral hepatitis (hbv, hcv), hiv infection, any other uncontrolled infection
    Description

    Viral hepatitis | Hepatitis B | Hepatitis C | HIV Infection | Communicable Disease Uncontrolled

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0042721
    UMLS CUI [2]
    C0019163
    UMLS CUI [3]
    C0019196
    UMLS CUI [4]
    C0019693
    UMLS CUI [5,1]
    C0009450
    UMLS CUI [5,2]
    C0205318
    pregnancy and nursing period
    Description

    Pregnancy | Breast Feeding

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    Retour au début de la page

    Similar models

    Eligibility B-cell Lymphoma NCT01788189

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Age
    Item
    age ≥ 18 years
    boolean
    C0001779 (UMLS CUI [1])
    ECOG performance status
    Item
    performance status ecog 0 - 3
    boolean
    C1520224 (UMLS CUI [1])
    Recurrent Aggressive Adult Non-Hodgkin Lymphoma B-Cell CD20 positive | Non-Hodgkin's lymphoma aggressive refractory B-Cell CD20 positive | Exception Mantle cell lymphoma
    Item
    first or subsequent relapse or refractoriness of a biopsy-proven cd20-positive aggressive b cell lymphoma (excluding mantle cell lymphoma)
    boolean
    C0677726 (UMLS CUI [1,1])
    C0004561 (UMLS CUI [1,2])
    C3888518 (UMLS CUI [1,3])
    C0854870 (UMLS CUI [2,1])
    C0004561 (UMLS CUI [2,2])
    C3888518 (UMLS CUI [2,3])
    C1705847 (UMLS CUI [3,1])
    C0334634 (UMLS CUI [3,2])
    Measurable Disease
    Item
    measurable disease
    boolean
    C1513041 (UMLS CUI [1])
    Ineligibility High-Dose Chemotherapy with Autologous Stem Cell Transplant | High-Dose Chemotherapy with Autologous Stem Cell Transplant Unwilling
    Item
    ineligibility or unwillingness to undergo high-dose chemotherapy with autologous stem cell transplantation
    boolean
    C1512714 (UMLS CUI [1,1])
    C1512429 (UMLS CUI [1,2])
    C1512429 (UMLS CUI [2,1])
    C0558080 (UMLS CUI [2,2])
    Comprehension Study Protocol | Protocol Compliance
    Item
    ability to understand the aim of the study and act accordingly
    boolean
    C0162340 (UMLS CUI [1,1])
    C2348563 (UMLS CUI [1,2])
    C0525058 (UMLS CUI [2])
    Contraceptive methods
    Item
    effective contraception
    boolean
    C0700589 (UMLS CUI [1])
    Informed Consent
    Item
    signed informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Central nervous system lymphoma Aggressive Relapse
    Item
    central nervous system relapse of aggressive lymphoma
    boolean
    C0280803 (UMLS CUI [1,1])
    C0580822 (UMLS CUI [1,2])
    C0205336 (UMLS CUI [1,3])
    Medical condition Study Subject Participation Status Excluded | Laboratory test result abnormal Study Subject Participation Status Excluded | Mental disorder Study Subject Participation Status Excluded
    Item
    any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study
    boolean
    C3843040 (UMLS CUI [1,1])
    C2348568 (UMLS CUI [1,2])
    C0332196 (UMLS CUI [1,3])
    C0438215 (UMLS CUI [2,1])
    C2348568 (UMLS CUI [2,2])
    C0332196 (UMLS CUI [2,3])
    C0004936 (UMLS CUI [3,1])
    C2348568 (UMLS CUI [3,2])
    C0332196 (UMLS CUI [3,3])
    Condition Study Subject Participation Status At risk | Laboratory test result abnormal Study Subject Participation Status At risk
    Item
    any condition including the presence of laboratory abnormalities which places the subject at unacceptable risk if he/she were to participate in the study
    boolean
    C0348080 (UMLS CUI [1,1])
    C2348568 (UMLS CUI [1,2])
    C1444641 (UMLS CUI [1,3])
    C0438215 (UMLS CUI [2,1])
    C2348568 (UMLS CUI [2,2])
    C1444641 (UMLS CUI [2,3])
    Condition Interferes with Interpretation Research data
    Item
    any condition that confounds the ability to interpret data from the study
    boolean
    C0348080 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C0459471 (UMLS CUI [1,3])
    C0681873 (UMLS CUI [1,4])
    Organ function Inadequate | Relationship Absent Aggressive Lymphoma
    Item
    inadequate organ function not related to aggressive lymphoma:
    boolean
    C0678852 (UMLS CUI [1,1])
    C0205412 (UMLS CUI [1,2])
    C0439849 (UMLS CUI [2,1])
    C0332197 (UMLS CUI [2,2])
    C1332225 (UMLS CUI [2,3])
    Neutrophil count
    Item
    neutrophils < 1.0/nl
    boolean
    C0200633 (UMLS CUI [1])
    Platelet Count measurement
    Item
    platelets < 75/nl
    boolean
    C0032181 (UMLS CUI [1])
    Creatinine clearance measurement
    Item
    creatinine clearance < 60 ml/min
    boolean
    C0373595 (UMLS CUI [1])
    Bilirubin measurement
    Item
    bilirubin ≥ 2,5 mg/dl
    boolean
    C0344395 (UMLS CUI [1])
    Aspartate aminotransferase increased | Alanine aminotransferase increased
    Item
    serum ast/got or alt/gpt ≥ 4 x upper limit of normal
    boolean
    C0151904 (UMLS CUI [1])
    C0151905 (UMLS CUI [2])
    Viral hepatitis | Hepatitis B | Hepatitis C | HIV Infection | Communicable Disease Uncontrolled
    Item
    active viral hepatitis (hbv, hcv), hiv infection, any other uncontrolled infection
    boolean
    C0042721 (UMLS CUI [1])
    C0019163 (UMLS CUI [2])
    C0019196 (UMLS CUI [3])
    C0019693 (UMLS CUI [4])
    C0009450 (UMLS CUI [5,1])
    C0205318 (UMLS CUI [5,2])
    Pregnancy | Breast Feeding
    Item
    pregnancy and nursing period
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial